Clearmind Medicine Inc. (CMND)
NASDAQ: CMND · Real-Time Price · USD
0.737
+0.007 (1.01%)
At close: Apr 28, 2026, 4:00 PM EDT
0.717
-0.020 (-2.77%)
Pre-market: Apr 29, 2026, 7:36 AM EDT
Clearmind Medicine Market Cap
Clearmind Medicine has a market cap or net worth of $1.54 million as of April 29, 2026. Its market cap has decreased by -68.42% in one year.
Market Cap
1.54M
Enterprise Value
-8.80M
1-Year Change
-68.42%
Ranking
Category
Stock Price
$0.74
Market Cap Chart
Since August 16, 2021, Clearmind Medicine's market cap has decreased from $26.16M to $1.54M, a decrease of -94.11%. That is a compound annual growth rate of -45.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 1.54M | -43.26% |
| Dec 31, 2025 | 2.71M | -55.12% |
| Dec 31, 2024 | 6.05M | 27.14% |
| Dec 29, 2023 | 4.76M | -39.12% |
| Dec 30, 2022 | 7.82M | -59.15% |
| Dec 27, 2021 | 19.13M | -26.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Silexion Therapeutics | 2.58M |
| Calidi Biotherapeutics | 2.51M |
| HCW Biologics | 2.49M |
| Bone Biologics | 2.46M |
| Propanc Biopharma | 2.26M |
| Adial Pharmaceuticals | 2.23M |
| Biodexa Pharmaceuticals | 2.17M |
| Scinai Immunotherapeutics | 2.01M |